[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$ifrx](/topic/$ifrx)

### Top Social Posts

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"** HIGHEST IMPLIED VOLATILITY OPTIONS ** $NVDA $BYND $ADAP $ORBS $IFRX $BHVN $WWR $NVX $BITF"  
[X Link](https://x.com/QuantEmperor/status/1978910092549636315) [@QuantEmperor](/creator/x/QuantEmperor) 2025-10-16T19:45Z 2062 followers, XXX engagements


"@biotechsanya2 Not sure if this helps comparing $AMGN avacopan v INF904 $IFRX"  
[X Link](https://x.com/StreetCred2017/status/1978605196461695371) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-15T23:33Z XXX followers, XXX engagements


"$IFRX-- I *think* the main question is: did Avacopan fail because of insufficient blockade on of C5aR OR because C5aR s not rate-limiting If INF904 is a *better* Avacopan it DOESN'T matter if the reason why Ava' failed is that C5aR blockade doesn't achieve anything due to TNF-a signalling; other "Ils" is what drives signalling-- if the case is that C5aR blockade (IFRX thinks they have a more potent Ava') IS sufficient this COULD be a win. I think the odds of this working are minimal as we know that X C5a inhibitors have already failed that being said there's a small chance this hits as this"  
[X Link](https://x.com/biotechsanya2/status/1978587133511184878) [@biotechsanya2](/creator/x/biotechsanya2) 2025-10-15T22:21Z XXX followers, XXX engagements


"** HIGHEST IMPLIED VOLATILITY OPTIONS ** $WOLF $COIN $NVDA $EOSE $SQNS $BYND $CGEN $ADAP $IFRX $WWR $WULF $BHVN $ORBS $NVX"  
[X Link](https://x.com/QuantEmperor/status/1978547715492712493) [@QuantEmperor](/creator/x/QuantEmperor) 2025-10-15T19:45Z 2063 followers, XXX engagements